Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
7
×
Tags
boston blog main
7
×
deals
7
×
life sciences
national blog main
biotech
boston top stories
clinical trials
fda
national top stories
san francisco blog main
investing
new york blog main
new york top stories
san francisco top stories
boston
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
sarepta therapeutics
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
cancer
cystic fibrosis
drugs
eli lilly
gene therapy
What
fda
7
×
drug
bio
medicines
roundup
approval
approved
billion
deal
drugs
gene
news
roche
therapeutics
therapy
acquire
affects
agreed
ahead
americans
aren’t
asco
betting
biopharma
blueprint
branded
brings
cancer
candidate
cash
choices
cholesterol
commissioner
companies
company
compound
consumers
costly
counterweight
currently
Language
unset
Current search:
photo
×
fda
×
" boston blog main "
×
deals
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
